Clinical Trial

Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma

Study acronym: IGNITE-V
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to confirm prospectively if the use of near infrared-indocyanine green (NIR-ICG) alone offers similar accuracy and sensitivity to the gold standard dual technique for sentinel lymph node detection in early stage vulvar cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-08.
Status change: Not Yet Recruiting → Recruiting 2026-04-08
Trial Details
NCT Number NCT06039111
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: Juravinski Cancer Centre Foundation
Conditions Vulvar Cancer
Enrollment 58 participants
Start Date 2023-10-01
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-13